NMNAT2 anticorps (Intracellular)

N° du produit ABIN7581919

Cet anticorps Lapin Polyclonal détecte spécifiquement NMNAT2 dans WB et IHC. Il présente une réactivité envers Souris.

Aperçu rapide pour NMNAT2 anticorps (Intracellular) (ABIN7581919)

Antigène: NMNAT2 (Nicotinamide Nucleotide Adenylyltransferase 2 (NMNAT2))

Reactivité: Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp NMNAT2 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Détail du produit anti-NMNAT2 anticorps

Épitope: AA 131-146, Intracellular

Fonction: A Rabbit Polyclonal Antibody to NMNAT2

Séquence: (C)HENTQPIYQN SNVPTK

Specificité: Intracellular.

Homologie: Rat - identical,Human12,16 identical.

Attributs du produit: Anti-NMNAT2 Antibody (ABIN7581919) is a highly specific antibody directed against an epitope of the mouse protein. The antibody can be used in western blot and immunohistochemistry applications. It has been designed to recognize NMNAT2 from mouse, rat and human samples.

Purification: Affinity purified on immobilized antigen.

Immunogène: (C)HENTQPIYQNSNVPTK, corresponding to amino acid residues 131 - 146 of mouse NMNAT2

Isotype: IgG

Information d'application

Indications d'application: Antigen preadsorption control: 1 μg peptide per 1 μg antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: 0.2 mL double distilled water (DDW).

Concentration: 1 mg/mL

Buffer: PBS pH 7.4

Stock: 4 °C,-20 °C

Stockage commentaire:

Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.

Storage after reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).

Détails sur NMNAT2

Antigène: NMNAT2 (Nicotinamide Nucleotide Adenylyltransferase 2 (NMNAT2))

Autre désignation: NMNAT2 

Sujet: Nicotinamide mononucleotide adenylyltransferase 2, Nicotinamide Nucleotide Adenylyltransferase 2, Nicotinamide/Nicotinic Acid Mononucleotide Adenylyltransferase 2, NMN adenylyltransferase 2,Nicotinamide mononucleotide adenylyltransferase 2, also referred to as NMNAT2, belongs to the NMNAT family of enzymes responsible for NAD+ biosynthesis. This family catalyzes the final step in NAD+ production, converting nicotinamide mononucleotide (NMN) and ATP to NAD+. NMNAT2 is predominantly localized in the cytoplasm and Golgi apparatus, distinguishing it from NMNAT1 (nuclear) and NMNAT3 (mitochondrial) counterparts. Structurally, NMNATs share conserved ATP-binding motifs crucial for their enzymatic functions1-3. In addition to its enzymatic role, NMNAT2 also functions as a chaperone, mitigating protein aggregation under proteotoxic stress. Its enzymatic and chaperone activities are recruited in a context-dependent manner, protecting against excitotoxicity and proteotoxic stress, respectively. This dual functionality highlights its significance in cellular stress responses5. NMNAT2 plays a critical role in cellular energy metabolism by maintaining NAD+ pools, essential for redox reactions and the activity of sirtuins and PARPs, key regulators of gene expression and stress responses. NMNAT2's cytoplasmic localization facilitates its involvement in glucose metabolism and the regulation of compartmentalized NAD+ availability, which is crucial for processes like adipogenesis4. In neurons, NMNAT2 contributes to axonal protection and integrity by modulating NAD+-dependent repair pathways, highlighting its neuroprotective roles5. NMNAT2 protein levels are tightly regulated post-transcriptionally, with a short half-life necessitating constant replenishment, and its expression is induced by glucose metabolism3. Tissue-specific expression studies reveal that NMNAT2 is highly abundant in the brain, heart, and skeletal muscle, reflecting its importance in energy-demanding tissues. At the cellular level, its expression is notable in neurons, cardiomyocytes, and other metabolically active cells3-5. Clinically, reduced NMNAT2 levels have been observed in neurodegenerative diseases like Alzheimer's, where its decline precedes neurodegeneration, underscoring its potential as a therapeutic target. Dysregulated NMNAT2 activity has also been implicated in cardiac hypertrophy, demonstrating its broad relevance in disease pathophysiology1,3,5.

ID gène: 226518

UniProt: Q8BNJ3